Experimental paracoccidioidomycosis of the Syrian hamster: Fungicidal activity and production of inflammatory cytokines by macrophages

Medical Mycology

Volumn 38, Issue 1, 2000, Pages 51-60

  Parise Fortes, M R ^a   Pereira Da Silva, M F ^a   Sugizaki, M F ^a   Defaveri, J ^a   Montenegro, M R ^a   Soares, A M V C ^a   Peraçoli, Maria Terezinha Serrão ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Hamsters; Interleukin 1; Paracoccidioidomycosis; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FUNGICIDAL ACTIVITY; HAMSTER; INFECTION RESISTANCE; INFLAMMATION; LIVER METASTASIS; LYMPH NODE METASTASIS; MACROPHAGE FUNCTION; MALE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PHAGOCYTOSIS; SOUTH AMERICAN BLASTOMYCOSIS;

ANIMALIA; CRICETINAE; FUNGI; MESOCRICETUS AURATUS; PARACOCCIDIOIDES BRASILIENSIS; PARACOCCIDIOIDOMYCOSIS BRASILIENSIS;

EID: 0033996224     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.38.1.51.60     Document Type: Article

References (42)

1. Restrepo A. The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved. J Med Vet Mycol 1985; 23: 323-334.
2. McEwen JG, Bedoya V, Patiño MM, Salazar ME, Restrepo A. Experimental murine paracoccidioidomycosis induced by inhalation of conidia. J Med Vet Mycol 1987; 25: 165-175.
3. Franco M, Mendes RP, Moscardi-Bacchi M, Rezkallah-Iwasso MT, Montenegro MR. Paracoccidioidomycosis. Bail Clin Trop Med Commun Dis 1989; 4: 185-220.
4. Musatti CC, Peraçoli MTS, Campos-Soares AMV, Rezkallah-Iwasso MT. Cell-mediated immunity in patients with paracoccidioidomycosis. In: Franco M, Lacaz CS, Restrepo-Moreno A, Del Negro G, eds. Paracoccidioidomycosis. Boca Raton: CRC Press, 1994: 175-186.
5. Louie A, Baltch AL, Smith RP, Franke MA, Ritz WJ, Singh JK, Gordon MA. Tumor necrosis factor alpha has a protective role in murine model of systemic candidiasis. Infect Immun 1994; 62: 2761-2772.
6. Smith JG, Magee DM, Williams DM. Graybill JR. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. J Infect Dis 1990; 162: 1349-1353.
7. Brummer E, Hanson LH, Restrepo A, Stevens DA. In vivo and in vitro activation of pulmonary macrophages by IFN-gamma for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis. J Immunol 1988; 140: 2786-2789.
8. Crott LSP, Valim YML, Silva CL, Barbosa JE. The role of the complement system in the neutrophil functions stimulated in vitro by an alkali-insoluble cell wall fraction of Paracoccidioides brasiliensis. J Med Vet Mycol 1993; 31: 17-27.
9. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44: 153-205.
10. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Ann Rev Med 1994; 45: 491-503.
11. Dooley DP, Cox RA, Hestilow KL, Dolan MJ, Magee DM. Cytokine induction in human coccidioidomycosis. Infect Immun 1994; 62: 3980-3983.
12. Okomo-Assoumou MC, Daulouede S, Lemesre JL, N'Zila-Mouanda A, Vincendeau P. Correlation of high serum levels of tumor necrosis factor-α with disease severity in human african trypanosomiasis. Am J Trop Med Hyg 1995; 53: 539-543.
13. Silva CL, Sliva MF, Faccioli LH, Pietro CL, Cortez SAE, Foss NT. Differential correlation between interleukin patterns in disseminated and chronic human paracoccidioidomycosis. Clin Exp Immunol 1995; 101: 314-320.
14. Le J, Vilcek J. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activilies. Lab Invest 1987; 56: 234-248.
15. Westendorp RGJ, Langermans JAM, De Bel CE, et al. Release of tumor necrosis factor: an innate host characteristic that may contribute to the outcome of meningococcal disease. J Infect Dis 1995; 171: 1057-1060.
16. Frenkle JK. Experimental biology: use in infectious disease research. In: Van Hoosier GL, McPherson CW, eds. Laboratory Hamsters. New York: Academic Press Inc, 1987: 227-249.
17. Melby PC, Tryon VV, Chandrasekar B, Freeman GL. Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental leishmaniasis. Infect Immun 1998; 66: 2135-2142.
18. Coelho KIR, Defaveri J, Rezkallah-Iwasso MT. Peraçoli MTS. Experimental paracoccidioidomycosis. In: Franco M, Lacaz CS, Restrepo-Moreno A, Del Negro G, eds. Paracoccidioidomycosis. Boca Raton: CRC Press, 1994: 87-107.
19. Peraçoli MTS, Mota NGS, Montenegro MR. Experimental paracoccidioidomycosis in the Syrian hamster: morphology and correlation of lesions with humoral and cell-mediated immunity. Mycopathologia 1982; 79: 7-17.
20. Peraçoli MTS. Fortes MRP, Pereira Da Sliva MF, Montenegro MR. Natural killer cell activity in experimenlal paracoccidioidomycosis of the Syrian hamster. Rev Inst Med Trop São Paulo 1995; 37: 129-136.
21. Fava Netto C, Vegas VS, Sciannamea IM, Guarnieri DB. Antígeno polissacarídico do Paracoccidioides brasiliensis: estudo do tempo de cultivo do P. brasiliensis necessário ao preparo do antígeno. Rev Inst Med Trop São Paulo 1969; 11: 177-181.
22. Calich VLG, Purchio A, Paula CR. A new fluorescent viability test for fungi cells. Mycopathologia 1978; 66: 175-177.
23. Casals JB. Tablet sensitivity testing of pathogenic fungi. J Clin Pathol 1979; 32: 719-722.
24. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-275.
25. Rabinovitch M, Manejias RE, Russo M, Abbey EE. Increased spreading of macrophage from mice treated with interferon inducers. Cell Immunol 1977; 29: 86-95.
26. Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burger E, Calich VLG. The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis. J Med Vet Mycol 1992; 30: 261-264.
27. Figueiredo F, Alves LMC, Silva CL. Tumor necrosis factor production in vivo and in vitro in response to Paracoccidioides brasiliensis and the cell wall fractions thereof. Clin Exp Immunol 1993; 93: 189-194.
28. Godfrey KAM. Statistic in practice. Comparing the means of several groups. N Engl J Med 1985; 313: 450-456.
29. Kashino SS, Fazioli RA, Moscardi-Bacchi M, et al. Effect of macrophage blockade on the resistance of inbred mice to Paracoccidioides brasiliensis infection. Mycopathologia 1995; 130: 131-140.
30. Iabuki K, Montenegro MR. Experimental paracoccidioidomycosis in the Syrian hamster: morphology, ultrastructure and correlation of lesions with presence of specific antigens and serum level of antibodies. Mycopathologia 1979; 67: 131-141.
31. Flory CM, Jones ML, Miller BF, Warren JS. Regulatory roles of tumor necrosis factor-α and Interleukin-1β in monocyte chemoattractant protein-1 mediated pulmonary granuloma formation in the rat. Am J Pathol 1995; 146: 450-462.
32. Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab Invent 1991; 64: 724-742.
33. Jouault T, Bernigaud A, Lepage G, Trinel PA, Poulain D. The Candida albicans phospholipomannan induces in vitro production of tumor necrosis factor-α from human and murine macrophages. Immunology 1994; 83: 268-273.
34. Wu-Hsieh BA. Lee GS, Franco MF, Hoffman FM. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun 1992; 66: 4230-4238.
35. Watson SR, Schmitt SK, Hendricks DE, Bullock WE. Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2. J Immunol 1985; 135: 3487-3493.
36. Kist A, Ho AD, Rath U, et al. Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor. Blood 1988; 72: 344-348.
37. Holtmann H, Wallach D. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4b-phorbol-12-myristate-13-acetate. J Immunol 1987; 139: 1161-1167.
38. Bodgan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991; 174: 1549-1555.
39. 2 production and anti-Leishmanial capacity of human cultured monocytes mediated by IFN-gamma. J Immunol 1989; 143: 3020-3024.
40. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor β. Nature 1988; 334: 260-262.
41. Pearson RD, Evans T, Smith D, Wiedel D, Mason K, Castracane J. Wasting and macrophage production of interleukin 1 and tumor necrosis factor/cachectin in visceral leishmaniasis. Clin Res 1988; 36: 466A(Abstract).
42. Truyens C, Torrico F, AngeloBarrios A, et al. The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNFα, but not by anti-IL-6 or anti-IFN-γ antibodies. Parasit Immunol 1995; 17: 561-568.